New out-patient reimbursement codes for prescription of health apps in Germany

30

Mar 2021

On March 17, 2021, the Evaluation Committee (Bewertungsausschuss) has decided to introduce two new EBM (German Uniform Evaluation Standard) codes related to health apps with retrospective effect from January 1, 2021.

The following codes will be introduced under the EBM sub-chapter 1.4 “Visits, the examination of home care, prescribing special treatment measures, administrative complex, telephone consultation, consult flat rate, stay”:

  • 01470 “Additional flat rate for issuing an initial prescription for a digital health application (DiGA) from the directory in accordance with Section 139e SGB V” (Zusatzpauschale für das Ausstellen einer Erstverordnung einer digitalen Gesundheitsanwendung (DiGA) aus dem Verzeichnis gemäß § 139e SGB V) with a value of 18 points (equal to approximately €2.00)
  • 01471 “Additional flat rate for the follow-up and the evaluation of the digital health application (DiGA) somnio” (Zusatzpauschale für die Verlaufskontrolle und die Auswertung der digitalen Gesundheitsanwendung (DiGA) somnio) with a value of 64 points (equal to approximately €7.12)

The reimbursement of services in the public outpatient sector in Germany is regulated in the EBM catalog (Einheitlicher Bewertungsmaßstab), updated once a quarter (4 times a year). The updated EBM catalog for the second quarter of 2021 is expected to be available at the beginning of April 2021.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more